A novel anticancer theranostic pro-prodrug based on hypoxia and photo sequential control.
Journal: 2016/July - Chemical Communications
ISSN: 1364-548X
PUBMED: 27379361
DOI: 10.1039/c6cc02932a
Abstract:
A novel anticancer pro-prodrug (GMC-CAE-NO2) with diagnosis and therapy functions based on hypoxia and photo sequential control was designed. It provides a platform for constructing theranostic pro-prodrugs to release active drugs controlled by hypoxic status and UV illumination.
Open in
Relations:
Citations
(4)
Affiliates
(1)
Similar articles
Discussion board
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.
Search and select entities to see details here. Details will include lists of related entities (via publication). Explore related entities further.